Skip to main content
. 2024 Jul 4;23:232. doi: 10.1186/s12933-024-02343-7

Table 1.

Baseline characteristics of participants, stratified by NAFLD or MASLD status: NHANES III (1988–1994)

Characteristics NAFLD
(n = 3672 )
Non-NAFLD
(n = 6718)
p value MASLD
(n = 3556)
Non-MASLD
(n = 6834)
p value
Age (years) 45.0 (33.0, 61.0) 39.0 (39.0, 55.0) <0.001 46.0 (35.0, 61.0) 38.0 (28.0, 54.0) <0.001
Male, n (%) 1764 (51.6) 3146 (48.5) 0.246 1743 (53.6) 3167 (47.6) 0.01
Race/ethnicity, n (%) <0.001 <0.001
Non-Hispanic white 1315 (67.2) 2563 (69.9) 1249 (65.9) 2629 (70.4)
Non-Hispanic black 964 (12.4) 2234 (15.5) 923 (12.6) 2275 (15.3)
Mexican-American 1236 (14.5) 1563 (8.3) 1225 (15.1) 1574 (8.2)
Other race 157(5.8) 358 (6.3) 159 (6.3) 356 (6.0)
Low income, n (%) 1302 (22.0) 2174 (19.1) 0.002 1290 (23.4) 2182 (18.5) <0.001
Married, n (%) 2265 (68.2) 3738 (62.9) <0.001 2213 (68.5) 3790 (62.9) <0.001
College degree, n (%) 392 (19.4) 1020 (24.4) <0.001 356 (17.7) 1056 (25.1) <0.001
Current smoker, n (%) 873 (22.6) 2039 (30.1) <0.001 857 (22.9) 2055 (29.8) <0.001
Sedentary lifestyle, n (%) 1262 (26.4) 1847 (19.7) <0.001 1265 (27.3) 1844 (19.5) <0.001
BMI (kg/m2) 28.7 (24.9, 33.1) 25.4 (22.6, 28.7) <0.001 29.2 (25.7, 33.4) 25.1 (22.4, 28.5) <0.001
WC (cm) 99.0 (88.2, 109.0) 89.0 (80.0, 97.9) <0.001 100.1 (90.7, 109.6) 88.3 (79.1, 97.4) <0.001
Diabetes, n (%) 704 (15.6) 475 (5.3) <0.001 722 (17.0) 457 (4.9) <0.001
Hypertension, n (%) 1528 (38.9) 1922 (25.4) <0.001 1580 (42.3) 1870 (24.1) <0.001
TG (mg/dL) 137.5 (89.0, 209.0) 97.0 (69.0, 140.0) <0.001 143.0 (95.0, 215.0) 95.0 (68.0, 137.0) <0.001
HDL-C (mg/dL) 45.0 (37.0, 54.0) 50.0 (42.0, 61.0) <0.001 44.0 (37.0, 53.0) 51.0 (42.0, 61.0) <0.001
HbA1c (%) 5.5 (5.1, 5.9) 5.3 (5.0, 5.6) <0.001 5.5 (5.1, 5.9) 5.3 (5.0, 5.6) <0.001
Glucose (mg/dL) 95.8 (88.7, 105.8) 91.9 (86.4, 98.6) <0.001 96.7 (89.7, 107.2) 91.6 (86.2, 98.2) <0.001
Insulin (uU/mL) 12.23 (8.02, 19.44) 8.12 (5.85, 11.81) <0.001 12.81 (8.53, 20.22) 7.95 (5.78, 11.52) <0.001
HOMA-IR 3.00 (1.85, 5.15) 1.85 (1.30, 2.80) <0.001 3.16 (1.98, 5.40) 1.81 (1.28, 2.72) <0.001
TyG index 8.84 (8.34, 9.33) 8.40 (8.05, 8.83) <0.001 8.88 (8.42, 9.37) 8.37 (8.03, 8.80) <0.001
TyG-BMI index 260.11 (215.54,) 215.14 (186.17, 249.09) <0.001 264.59 (224.74, 306.62) 212.92 (183.37, 247.23) <0.001
TyG-WC index 888.01 (758.99,1002.91) 752.18 (656.87,850.9) <0.001 900.35 (786.69, 1012.19) 744.92 (647.69, 844.88) <0.001
NFS −2.05 (−3.09, −0.86) −2.47 (−3.34, −1.45) <0.001 −1.94 ( −3.00, −0.77) −2.50 ( −3.36, −1.50) <0.001
NFS >-1.455, n (%) 1339 (33.8) 1690 (23.0) <0.001 1368 (36.4) 1661 (22.0) <0.001
FIB-4 0.82 (0.56, 1.24) 0.75 (0.52, 1.15) <0.001 0.85 (0.58, 1.27) 0.74 (0.51, 1.13) <0.001
FIB-4 > 1.3, n (%) 806 (22.3) 1250 (17.5) <0.001 830 (24.0) 1226 (16.8) <0.001
Cumulative mortality, n (%)
All cause 1466 (37.6) 2062 (27.3) <0.001 1508 (40.7) 2019 (26.0) <0.001
Cardiovascular specific 391 (9.6) 546 (6.7) <0.001 398 (10.4) 539 (6.4) <0.001
Diabetes specific 70 (1.6) 62 (0.6) <0.001 76 (1.8) 56 (0.5) <0.001

Data are displayed as the median (interquartile range) or unweighted frequency counts (weighted percentage) as appropriate. The Mann-Whitney test for continuous variables and the Rao-Scott chi-square test for categorical variables were used in this analysis

BMI, body mass index; FIB-4, fibrosis-4 index; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; MASLD, metabolic dysfunction-associated steatotic liver disease; NAFLD, non-alcoholic fatty liver disease; NFS, NAFLD Fibrosis Score; TG, triglycerides; TyG, triglyceride-glucose; WC, waist circumference